# Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII

Study · id `cardio:ct-nct01918150` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01918150](<https://clinicaltrials.gov/study/NCT01918150>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01918150

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1350 participants.

## Technical summary

Registry record NCT01918150. Randomized; single masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1350 participants (planned count; ClinicalTrials.gov record NCT01918150, source copy `cardio:ctgov-nct01918150-2014-01-08`, retrieved 2026-10-31)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01918150, source copy `cardio:ctgov-nct01918150-2014-01-08`, retrieved 2026-10-31)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01918150, source copy `cardio:ctgov-nct01918150-2014-01-08`, retrieved 2026-10-31)
- Completion: 2016-03 (anticipated) (ClinicalTrials.gov record NCT01918150, source copy `cardio:ctgov-nct01918150-2014-01-08`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT01918150, source copy `cardio:ctgov-nct01918150-2014-01-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01918150-2014-01-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII
- Acronym: EVIDENCE II
- Condition: Silent Myocardial Infarction
- Condition: Stable Angina
- Condition: Acute Coronary Syndrome
- Intervention (Device): Titan 2 stents
- Intervention (Device): Cobalt-Chromium Bare Metal Stents
- Lead sponsor: Hexacath, France
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)

## Provenance

Content hash: c7ded09db430504ccb3a448ee22717a0f884dbc6e6be97091c6fa4858a8fb132
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
